BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 28, 2014
View Archived Issues
Bavarian Nordic presents novel RSV vaccines
Read More
Identification of small molecules that specifically target precursor microRNAs
Read More
Stem cell epigenetic DNA methylation signature for leukemia prognosis
Read More
QIAGEN launches careHPV Test in India
Read More
Bayer plans to acquire Dihon Pharmaceutical in China
Read More
EMA accepts tedizolid phosphate MAA for review
Read More
Anacor Pharmaceuticals completes end-of-phase II meeting with the FDA for AN-2728
Read More
QLT reports data from phase Ib trial of QLT-091001
Read More
Alzheimer's Drug Discovery Foundation funds research in gene therapy
Read More
AtheroNova reports preliminary phase I date for AHRO-001
Read More
Immune Design treats first patient in phase I trial of ID-G305
Read More
Salix Pharmaceuticals and RedHill Biopharma form exclusive agreement for RHB-106
Read More
Novel DNA-damaging quinone compounds disclosed by the University of Salford
Read More
La Jolla Pharmaceutical signs agreement with George Washington University for LJPC-501
Read More
Covidien closes its acquisition of Given Imaging
Read More
EMA accepts MAA filing for oritavancin
Read More
French investigators divulge novel compounds for cancer
Read More
Investigators prepare novel nanovesicles to stimulate healing
Read More
Forest Laboratories submits NDA to FDA for nebivolol/valsartan combination
Read More
U.S. researchers disclose new EGFRvIII-derived cancer vaccines
Read More
Astellas assumes full responsibility for isavuconazole in U.S. and Canada
Read More
Takeda seeks Japanese approval for TAK-438 for acid-related diseases
Read More
Rare Disease Day News: Adaptive licensing, EryDex shows benefit in ataxia telangiectasia
Read More
Cannabidol receives FDA orphan drug status for Lennox-Gastaut syndrome
Read More
FDA grants orphan drug status to pracinostat for AML
Read More